Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medicem Technology is a Czech-based medical device and biotechnology company that specializes in the development of innovative products using proprietary polymer and hydrogel technologies. The company's flagship product, Dilapan-S, is a synthetic osmotic dilator used globally for cervical ripening and labor induction, providing a non-pharmacological alternative to prostaglandins. Medicem also develops advanced solutions in ophthalmology, most notably the WIOL-CF polyfocal intraocular lens, which is designed to mimic the natural function of the human eye. The company integrates in-house research, development, and high-precision manufacturing to address unmet needs in women's health and surgical specialties. Medicem is recognized for its focus on safety and predictability in clinical outcomes through its unique AQUACORE hydrogel platform.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Medicem Technology.